Examination of Noninferiority, Safety, and Tolerability of Lopinavir/ritonavir and Raltegravir Compared with Lopinavir/ritonavir and Tenofovir/ Emtricitabine in Antiretroviral-Naïve Subjects: The PROGRESS Study, 48-Week Results-Reference-Cited by-同舟云学术

Examination of Noninferiority, Safety, and Tolerability of Lopinavir/ritonavir and Raltegravir Compared with Lopinavir/ritonavir and Tenofovir/ Emtricitabine in Antiretroviral-Naïve Subjects: The PROGRESS Study, 48-Week Results

Published:2011-10 Issue:5 Volume:12 Page:255-267
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Reynes Jacques,Lawal Adebayo,Pulido Federico,Soto-Malave Ruth,Gathe Joseph,Tian Min,Fredrick Linda M.,Podsadecki Thomas J.,Nilius Angela M.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/hct1205-255

Reference14 articles.

1. Tenofovir disoproxil fumarate–emtricitabine coformulation for once-daily dual NRTI backbone

3. Renal Tubular Dysfunction Associated With Tenofovir Therapy

4. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of two binomial proportions in noninferiority confirmatory trials;Pharmaceutical Statistics;2023-12-11

2. Evaluation of treatment efficacy after switching to dolutegravir-lamivudine dual therapy in people living with HIV;African Health Sciences;2022-10-28

3. Effectiveness and Safety Analysis of PIs/r Based Dual Therapy in Treatment-Naïve, HIV/AIDS Patients: A Network Meta Analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2022-03-04

4. Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application;Current Drug Research Reviews;2021-12-07

5. Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis;Clinical Microbiology and Infection;2021-01